| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| SDZ.SW - | HOLD | 0 @ CHF 68.641 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 68.641. The average price that SDZ.SW shares were previous bought at was CHF 45.334. The current market price is 51.4% higher than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 299,930 compared to the previous valuation of however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |
| LONN.SW - | HOLD | 0 @ CHF 598.668 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 598.668. The average price that LONN.SW shares were previous bought at was CHF 604.613. The current market price is -1.0% lower than average price they were purchased at. The value of the holding in LONN.SW has increased by CHF 10,598 compared to the previous valuation of however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 127.7 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 127.7. The average price that MRK.DE shares were previous bought at was EUR 116.341. The current market price is 9.8% higher than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 38,351 compared to the previous valuation of Merck KGaA |
| NOVN.SW - | HOLD | 0 @ CHF 124.649 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 124.649. The average price that NOVN.SW shares were previous bought at was CHF 102.38. The current market price is 21.8% higher than average price they were purchased at. The value of the holding in NOVN.SW has increased by CHF 494,511 compared to the previous valuation of however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 53.7421 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 53.7421. The average price that NOVO-B.CO shares were previous bought at was DKK 62.0089. The current market price is -13.3% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has increased by DKK 853,833 compared to the previous valuation of Novo Nordisk A/S however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |
| NSIS-B.CO - | HOLD | 0 @ DKK 54.1104 | DKK 0 | The current share valuation price of NSIS-B.CO based on adjusted close was DKK 54.1104. The average price that NSIS-B.CO shares were previous bought at was DKK 60.4828. The current market price is -10.5% lower than average price they were purchased at. The value of the holding in NSIS-B.CO has fallen by DKK 137,810 compared to the previous valuation of |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 70.1 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 70.1. The average price that ORNBV.HE shares were previous bought at was EUR 60.3732. The current market price is 16.1% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 32,170 compared to the previous valuation of Orion Oyj however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 24.84 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 24.84. The average price that PHIA.AS shares were previous bought at was EUR 21.2058. The current market price is 17.1% higher than average price they were purchased at. The value of the holding in PHIA.AS has fallen by EUR 168,745 compared to the previous valuation of Koninklijke Philips NV |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 46.9 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 46.9. The average price that REC.MI shares were previous bought at was EUR 53.1347. The current market price is -11.7% lower than average price they were purchased at. The value of the holding in REC.MI has increased by EUR 9,362 compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 375.219 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 375.219. The average price that ROG.SW shares were previous bought at was CHF 286.083. The current market price is 31.2% higher than average price they were purchased at. The value of the holding in ROG.SW has increased by CHF 90,313 compared to the previous valuation of however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 79.31 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 79.31. The average price that SAN.PA shares were previous bought at was EUR 88.5053. The current market price is -10.4% lower than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 216,845 compared to the previous valuation of Sanofi SA |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 136.6 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 136.6. The average price that IPN.PA shares were previous bought at was EUR 104.662. The current market price is 30.5% higher than average price they were purchased at. The value of the holding in IPN.PA has increased by EUR 9,287 compared to the previous valuation of Ipsen SA however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 43.3 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 43.3. The average price that SHL.DE shares were previous bought at was EUR 47.75. The current market price is -9.3% lower than average price they were purchased at. The value of the holding in SHL.DE has fallen by EUR 111,881 compared to the previous valuation of Siemens Healthineers AG |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 14.1379 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 14.1379. The average price that SN.L shares were previous bought at was GBP 12.8575. The current market price is 10.0% higher than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 20,269 compared to the previous valuation of Smith & Nephew PLC |
| SOBI.ST - | HOLD | 0 @ SEK 32.3369 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 32.3369. The average price that SOBI.ST shares were previous bought at was SEK 26.7916. The current market price is 20.7% higher than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 86,633 compared to the previous valuation of however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 237.786 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 237.786. The average price that SOON.SW shares were previous bought at was CHF 268.015. The current market price is -11.3% lower than average price they were purchased at. The value of the holding in SOON.SW has fallen by CHF 39,336 compared to the previous valuation of |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 258.8 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 258.8. The average price that SRT3.DE shares were previous bought at was EUR 217.994. The current market price is 18.7% higher than average price they were purchased at. The value of the holding in SRT3.DE has fallen by EUR 27,591 compared to the previous valuation of Sartorius AG |
| STMN.SW - | HOLD | 0 @ CHF 104.147 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 104.147. The average price that STMN.SW shares were previous bought at was CHF 112.761. The current market price is -7.6% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 72,238 compared to the previous valuation of |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ EUR 221 | EUR 0 | The current share valuation price of TUB.BR based on adjusted close was EUR 221. The average price that TUB.BR shares were previous bought at was EUR 134.464. The current market price is 64.4% higher than average price they were purchased at. The value of the holding in TUB.BR has fallen by EUR 8,992 compared to the previous valuation of Financiere de Tubize SA |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 257.4 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 257.4. The average price that UCB.BR shares were previous bought at was EUR 167.894. The current market price is 53.3% higher than average price they were purchased at. The value of the holding in UCB.BR has fallen by EUR 78,737 compared to the previous valuation of UCB SA |
| ZEAL.CO - | HOLD | 0 @ DKK 57.0428 | DKK 0 | The current share valuation price of ZEAL.CO based on adjusted close was DKK 57.0428. The average price that ZEAL.CO shares were previous bought at was DKK 59.1439. The current market price is -3.6% lower than average price they were purchased at. The value of the holding in ZEAL.CO has fallen by DKK 27,801 compared to the previous valuation of |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 265.1 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 265.1. The average price that EL.PA shares were previous bought at was EUR 250.248. The current market price is 5.9% higher than average price they were purchased at. The value of the holding in EL.PA has fallen by EUR 384,021 compared to the previous valuation of EssilorLuxottica SA |
| ALC.SW - | HOLD | 0 @ CHF 68.102 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 68.102. The average price that ALC.SW shares were previous bought at was CHF 77.0204. The current market price is -11.6% lower than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 338,650 compared to the previous valuation of |
| AMP.MI - Amplifon SpA | HOLD | 0 @ EUR 13.91 | EUR 0 | The current share valuation price of AMP.MI based on adjusted close was EUR 13.91. The average price that AMP.MI shares were previous bought at was EUR 19.8189. The current market price is -29.8% lower than average price they were purchased at. The value of the holding in AMP.MI has increased by EUR 7,732 compared to the previous valuation of Amplifon SpA however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 701 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 701. The average price that ARGX.BR shares were previous bought at was EUR 525.504. The current market price is 33.4% higher than average price they were purchased at. The value of the holding in ARGX.BR has increased by EUR 52,126 compared to the previous valuation of Argenx SE however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 156.665 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 156.665. The average price that AZN.L shares were previous bought at was GBP 127.143. The current market price is 23.2% higher than average price they were purchased at. The value of the holding in AZN.L has increased by GBP 589,783 compared to the previous valuation of AstraZeneca PLC however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 44.555 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 44.555. The average price that BAYN.DE shares were previous bought at was EUR 26.2448. The current market price is 69.8% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 162,238 compared to the previous valuation of Bayer AG however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 103.7 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 103.7. The average price that BIM.PA shares were previous bought at was EUR 118.427. The current market price is -12.4% lower than average price they were purchased at. The value of the holding in BIM.PA has fallen by EUR 18,427 compared to the previous valuation of BioMerieux |
| COLO-B.CO - | HOLD | 0 @ DKK 72.5489 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 72.5489. The average price that COLO-B.CO shares were previous bought at was DKK 85.2136. The current market price is -14.9% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 97,593 compared to the previous valuation of |
| CTEC.L - ConvaTec Group PLC | HOLD | 0 @ GBP 2.69953 | GBP 0 | The current share valuation price of CTEC.L based on adjusted close was GBP 2.69953. The average price that CTEC.L shares were previous bought at was GBP 3.01533. The current market price is -10.5% lower than average price they were purchased at. The value of the holding in CTEC.L has fallen by GBP 15,899 compared to the previous valuation of ConvaTec Group PLC |
| DEMANT.CO - | HOLD | 0 @ DKK 30.7978 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 30.7978. The average price that DEMANT.CO shares were previous bought at was DKK 35.1227. The current market price is -12.3% lower than average price they were purchased at. The value of the holding in DEMANT.CO has fallen by DKK 21,172 compared to the previous valuation of |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 206 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 206. The average price that DIM.PA shares were previous bought at was EUR 199.575. The current market price is 3.2% higher than average price they were purchased at. The value of the holding in DIM.PA has fallen by EUR 42,084 compared to the previous valuation of Sartorius Stedim Biotech |
| ABVX.PA - Abivax SA | HOLD | 0 @ EUR 106.6 | EUR 0 | The current share valuation price of ABVX.PA based on adjusted close was EUR 106.6. The average price that ABVX.PA shares were previous bought at was EUR 100.227. The current market price is 6.4% higher than average price they were purchased at. The value of the holding in ABVX.PA has increased by EUR 67,062 compared to the previous valuation of Abivax SA however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 70.72 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 70.72. The average price that ERF.PA shares were previous bought at was EUR 58.4412. The current market price is 21.0% higher than average price they were purchased at. The value of the holding in ERF.PA has fallen by EUR 32,096 compared to the previous valuation of Eurofins Scientific SE |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 37.22 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 37.22. The average price that FME.DE shares were previous bought at was EUR 47.4075. The current market price is -21.5% lower than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 24,002 compared to the previous valuation of Fresenius Medical Care AG |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 48.37 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 48.37. The average price that FRE.DE shares were previous bought at was EUR 42.8728. The current market price is 12.8% higher than average price they were purchased at. The value of the holding in FRE.DE has fallen by EUR 17,401 compared to the previous valuation of Fresenius SE & Co KGaA |
| GALD.SW - | HOLD | 0 @ CHF 161.47 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 161.47. The average price that GALD.SW shares were previous bought at was CHF 128.821. The current market price is 25.3% higher than average price they were purchased at. The value of the holding in GALD.SW has fallen by CHF 153,501 compared to the previous valuation of |
| GMAB.CO - | HOLD | 0 @ DKK 285.214 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 285.214. The average price that GMAB.CO shares were previous bought at was DKK 192.304. The current market price is 48.3% higher than average price they were purchased at. The value of the holding in GMAB.CO has increased by DKK 44,505 compared to the previous valuation of however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 10.9 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 10.9. The average price that GRF.MC shares were previous bought at was EUR 10.445. The current market price is 4.4% higher than average price they were purchased at. The value of the holding in GRF.MC has increased by EUR 1,137 compared to the previous valuation of Grifols SA however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 20.7772 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 20.7772. The average price that GSK.L shares were previous bought at was GBP 17.2647. The current market price is 20.3% higher than average price they were purchased at. The value of the holding in GSK.L has increased by GBP 83,695 compared to the previous valuation of GlaxoSmithKline PLC however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 17.9277 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 17.9277. The average price that HIK.L shares were previous bought at was GBP 23.5355. The current market price is -23.8% lower than average price they were purchased at. The value of the holding in HIK.L has fallen by GBP 5,780 compared to the previous valuation of |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.38155 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.38155. The average price that HLN.L shares were previous bought at was GBP 4.55196. The current market price is -3.7% lower than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 144,854 compared to the previous valuation of Haleon PLC however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |